{"id":178197,"date":"2025-06-12T10:53:11","date_gmt":"2025-06-12T10:53:11","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/178197\/"},"modified":"2025-06-12T10:53:11","modified_gmt":"2025-06-12T10:53:11","slug":"smart-nanoparticles-launch-genetic-attack-on-lung-cancer-and-cystic-fibrosis","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/178197\/","title":{"rendered":"Smart nanoparticles launch genetic attack on lung cancer and cystic fibrosis"},"content":{"rendered":"<p id=\"first\">Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that transports genetic therapies directly to the lungs, opening promising possibilities for patients with conditions like lung cancer and cystic fibrosis.<\/p>\n<p>The research, led by Gaurav Sahay of Oregon State University&#8217;s College of Pharmacy, was conducted in collaboration with Oregon Health &amp; Science University and the University of Helsinki. Findings were published in a pair of papers, in Nature Communications and the Journal of the American Chemical Society.<\/p>\n<p>Scientists created and tested more than 150 different materials and discovered a new type of nanoparticle that can safely and effectively carry messenger RNA and gene-editing tools to lung cells. In studies with mice, the treatment slowed the growth of lung cancer and helped improve lung function that had been limited by cystic fibrosis, a condition caused by one faulty gene.<\/p>\n<p>Researchers also developed a chemical strategy to build a broad library of lung-targeting lipids used in the nanocarriers. These materials form the foundation for the new drug delivery system and could be customized to reach different organs in the body, Sahay said.<\/p>\n<p>&#8220;The streamlined synthesis method makes it easier to design future therapies for a wide range of diseases,&#8221; he said. &#8220;These results demonstrate the power of targeted delivery for genetic medicines. We were able to both activate the immune system to fight cancer and restore function in a genetic lung disease, without harmful side effects.&#8221;<\/p>\n<p>Oregon State&#8217;s K. Yu Vlasova, D.K. Sahel, Namratha Turuvekere Vittala Murthy, Milan Gautam and Antony Jozic were co-authors of the Nature Communications paper, which also included scientists from OHSU and the University of Helsinki. OSU&#8217;s Murthy, Jonas Renner, Milan Gautam, Emily Bodi and Antony Jozic teamed with Sahay on the other study.<\/p>\n<p>&#8220;Our long-term goal is to create safer, more effective treatments by delivering the right genetic tools to the right place,&#8221; said Sahay. &#8220;This is a major step in that direction.&#8221;<\/p>\n<p>These studies were funded by the Cystic Fibrosis Foundation, the National Cancer Institute and the National Heart, Lung and Blood Institute.<\/p>\n","protected":false},"excerpt":{"rendered":"Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that&hellip;\n","protected":false},"author":2,"featured_media":178198,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3846],"tags":[73463,267,70,16,15],"class_list":{"0":"post-178197","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-cystic-fibrosis-lung-cancer-lung-disease-diseases-and-conditions-personalized-medicine-copd-mesothelioma-gene-therapy","9":"tag-genetics","10":"tag-science","11":"tag-uk","12":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114670023749047183","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/178197","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=178197"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/178197\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/178198"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=178197"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=178197"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=178197"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}